1 Pharmaceutical Company's Accelerated Dividend

Questcor Pharmaceuticals (Nasdaq: QCOR  ) has decided to pay $0.20 per share to shareholders on Dec. 21 rather than its regularly scheduled Q1 payout, to get ahead of the fiscal cliff. One of the possibilities included in the fiscal cliff negotiations could raise dividend tax rates from their current 15% up to income tax rate percentages, so many companies are either giving special dividends or moving their regular dividends up into the next few weeks. Some have speculated that a number of these companies do this for not entirely generous reasons, in the cases of companies with a large percentage of internal ownership, but Questcor doesn't fall into that category, with insiders owning only 0.5% of its shares.

See more in the following video.

Questcor is one of the most debated names in all of biotech. Its premium priced drug, Acthar, is growing at a torrid pace -- and minting money in the process. However, recent events have created significant doubts about Questcor's future. Will insurance companies continue to cover the drug? Will a government investigation lead to huge fines? We highlight these high-profile issues inside our brand-new premium research report on Questcor. In it, you'll learn about the key opportunities and threats facing the company, as well as multiple reasons to buy and sell the stock. We're providing a full year of analyst updates as key news hits, so make sure to claim a copy today by clicking here now.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

DocumentId: 2139405, ~/Articles/ArticleHandler.aspx, 7/30/2014 9:48:51 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...


Advertisement